Oculis Holding Ag Share Price

NASDAQ: OCS

Small Cap

$17.75

+0.41

(+2.39%)

as on September 17, 2025 at 1:29 am IST

$₹

Oculis Holding Ag Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$17.35
Day's Price Range
$17.73
$17.75
2.25%
Downside
-0.11%
Upside
52 Week's Low
52 Week's High
$11.78
52-Week Price Range
$23.08
$17.75
33.63%
Downside
30.03%
Upside

Oculis Holding Ag share price movements today

Previous Close: $17.34
Open: $17.41
Volume: 57.6K
Day's Low - High: $17.35 - $17.73
52 Week Low - High: $11.78 - $23.08

Oculis Holding Ag Historical Returns

1 Month Return: -3.16 %
3 Month Return: -9.9 %
1 Year Return: + 44.82 %
3 Year Return: 0 %
5 Year Return: 0 %

Oculis Holding Ag Stock Fundamentals & Key Indicators

Check Oculis Holding Ag market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$910.6M

EPS (TTM)

-1.9575

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-75.7M

Revenue (TTM)

764.0K

Profit Margin

0.00%

Return On Equity TTM

934173800.00%

Oculis Holding Ag vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oculis Holding Ag with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Oculis Holding Ag	BUY	$910.6M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Oculis Holding Ag Stock including INR - Dollar returns

The Oculis Holding Ag stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Oculis Holding Ag investment value today

Current value as on today

₹1,53,155

Returns

₹53,155

(+53.15%)

Returns from Oculis Holding Ag Stock

₹48,287 (+48.29%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Oculis Holding Ag Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Oculis Holding Ag. Average target price of $37.76

Oculis Holding Ag Share Price Target

Get share price movements and forecasts by analysts on Oculis Holding Ag.

What analysts predicted

52.99%UPSIDE

Target Price

$37.76

Current Price

$17.75

Analyzed by

13 Analysts

Target

$37.76

Oculis Holding Ag target price $37.76, a slight upside of 52.99% compared to current price of $17.75. According to 13 analysts rating.

Oculis Holding Ag Stock's Interest Amongst Investors

Search interest for Oculis Holding Ag Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:40% versus previous 30 day period

Oculis Holding Ag Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	-	-	-	-
Gross Profit	-6	-6	-9	-9	-11	-18	-	-	-	-
Operating Income	-44	-10	-12	-12	-15	-22	-18	-17	-19	-20
EBITDA	-44	-12	-17	-12	-15	-21	-19	-28	-32	-25
Interest Expense	1	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-45	-12	-17	-12	-16	-20	-20	-28	-33	-25
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-49	-14	-19	-14	-18	-23	-23	-32	-37	-25
Net Profit Margin	-19212.94%	-5150.80%	-7951.14%	-6756.22%	-7249.10%	-8505.71%	0.00%	0.00%	0.00%	0.00%

Oculis Holding Ag Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	1	0	1	0
Gross Profit	-9	-9	-22	-32	-57
Operating Income	-12	-13	-32	-80	-73
EBITDA	-12	-12	-31	-45	-72
Interest Expense	2	5	6	1	0
Depreciation	0	0	0	0	0
Income Before Tax	-14	-18	-38	-88	-85
Income Tax Expense	0	0	0	0	0
Net Income	-16	-20	-41	-102	-96
Net Profit Margin	-1497.78%	-1932.50%	-4243.20%	-10056.85%	-12503.94%

Oculis Holding Ag Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-12	-17	-12	-16	-20	-20	-28	-33	-25
Operating Cash Flow	-13	-11	-13	-13	-13	-10	-10	-18	-17
Investing Cash Flow	-72	-3	21	-2	-18	4	-1	-51	25
Financing Cash Flow	33	0	0	0	51	0	2	103	0
Change in Cash	-54	-11	7	-13	19	-8	-7	32	4

Oculis Holding Ag Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-18	-38	-88	-85
Operating Cash Flow	-13	-25	-53	-47
Investing Cash Flow	0	-3	-54	-17
Financing Cash Flow	55	1	129	54
Change in Cash	41	-26	18	-10

Insights on Oculis Holding Ag

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -33.21M → -25.37M (in $), with an average increase of 30.9% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 185.0K → 245.0K (in $), with an average increase of 13.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 25.8%
NEGATIVE IMPACT
Price Dip
In the last 3 months, OCS stock has moved down by -9.9%

About Oculis Holding Ag

Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Organisation	Oculis Holding Ag
Headquarters	Bahnhofstrasse 20, Zug, Switzerland, 6300
CEO	Dr. Riad Sherif M.B.A., M.D.
E-voting on shares	Click here to vote

Key Management of Oculis Holding Ag

Name	Title
Ms. Gudrun Bachmann Ph.D.	Chief Technology Officer
Ms. Virginia R. Dean	Chief Human Resources Officer
Mr. Páll Ragnar Jóhannesson	Chief Business Officer
Ms. Rebecca Weil Ph.D.	Chief Commercial Officer
Dr. Riad Sherif M.B.A., M.D.	CEO & Director
Ms. Sylvia Cheung	Chief Financial Officer
Dr. Ramin Tadayoni M.D., Ph.D.	Chief Scientific Officer
Mr. Daniel S. Char J.D.	Chief Legal Officer
Dr. Snehal Shah Pharm.D.	President of Research & Development
Dr. Sharon Klier M.D., M.P.H.	Chief Development Officer

FAQs

What is Oculis Holding Ag share price today?

Oculis Holding Ag share price today is $17.75 as on September 17, 2025 at 1:29 am IST at the close of the market. Oculis Holding Ag share today touched a day high of $17.73 and a low of $17.35.

What is the 52 week high and 52 week low for Oculis Holding Ag share?

Oculis Holding Ag share touched a 52 week high of $23.08 on January 13, 2025 and a 52 week low of $11.78 on September 18, 2024. Oculis Holding Ag stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $17.75,which is 23.09% down from its 52 week high and 50.68% up from its 52 week low.

What is Oculis Holding Ag's market capitalisation today?

Oculis Holding Ag market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Oculis Holding Ag Stock (OCS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oculis Holding Ag on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oculis Holding Ag Shares that will get you 0.0845 shares as per Oculis Holding Ag share price of $17.75 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Oculis Holding Ag Stock (OCS) from India?

Indian investors can start investing in Oculis Holding Ag (OCS) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 2:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Oculis Holding Ag stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 2:41 am IST). Based on Oculis Holding Ag share’s latest price of $17.75 as on September 17, 2025 at 1:29 am IST, you will get 0.5634 shares of Oculis Holding Ag. Learn more about fractional shares .